Tongguo B. Si
Tianjin, 300308, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis.
Journal: Cancer biology & medicine
Published: March 17, 2026
Bronchial Arterial Chemoembolization with versus without Anlotinib in Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Case-Control Study.
Journal: Clinical interventions in aging
Published: December 16, 2025
Clinical outcomes and prognostic factors of systemic therapy combined with interventional treatment in hepatocellular carcinoma: a multicenter retrospective case series.
Journal: Translational cancer research
Published: September 02, 2025
Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging.
Journal: Frontiers in immunology
Published: March 20, 2025
Analysis of clinical efficacy and long-term prognosis of patients with hepatocellular carcinoma treated with PD-L1 inhibitor targeting.
Journal: Technology and health care : official journal of the European Society for Engineering and Medicine
Published: May 31, 2024
The aminophospholipid transporter, ATP8B3, as a potential biomarker and target for enhancing the therapeutic effect of PD-L1 blockade in colon adenocarcinoma.
Journal: Genomics
Published: April 10, 2024
Efficacy of argon-helium cryoablation combined with chemotherapy in the treatment of advanced NSCLC.
Efficacy of argon-helium cryoablation combined with chemotherapy in the treatment of advanced NSCLC.
Journal: Pakistan journal of medical sciences
Published: March 06, 2024
Efficacy and Safety of CT-guided Percutaneous Cryoablation for Hepatocellular Carcinoma at High-risk Sites.
Journal: Academic radiology
Published: January 09, 2024
ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer.
Journal: Discover oncology
Published: March 11, 2023
Retraction notice to "MicroRNA-498 disturbs the occurrence and aggression of colon cancer through targeting MDM2 to mediate PPARγ ubiquitination" [Life Sci. 277 (2021) 119225].
Journal: Life sciences
Published: February 22, 2023
The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells.
Journal: Frontiers in cell and developmental biology
Published: January 19, 2023
Last Updated: 09/26/2026